{
  "id": "650a4f88-c9e3-4ed5-bbe0-83bb106c1876",
  "title": "Healthcare Policy and Regulatory Decisions Under Scrutiny",
  "description": "Key healthcare appointments and FDA decisions drawing attention to Trump administration's health policy direction",
  "clusterIds": [
    "40ae16c2-8eda-4eba-adc7-aa2dd58bf34f",
    "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757"
  ],
  "arc": "Senate hearings for Trump's Surgeon General nominee focus on vaccine policy and decision-making authority, while the FDA's surprise rejection of a rare disease drug citing insufficient data highlights regulatory approach under the new administration.",
  "startedAt": "2026-02-26T21:05:24.898Z",
  "updatedAt": "2026-02-26T21:05:24.898Z",
  "status": "ongoing"
}